R

ResMed

RMD

214.550
USD
1.42
(0.67%)
Market Open
Volume
11,891
EPS
0
Div Yield
0
P/E
35
Market Cap
35,132,938,974
Related Instruments
A
AAP
-1.210
(-1.91%)
62.130 USD
ABT
4.220
(3.98%)
110.150 USD
B
BAX
0.190
(0.53%)
36.000 USD
BDX
-4.995
(-2.07%)
236.055 USD
BSX
1.315
(1.78%)
75.170 USD
C
CAH
2.570
(2.55%)
103.390 USD
C
COO
0.880
(0.94%)
94.200 USD
MDT
0.160
(0.20%)
80.470 USD
SYK
5.59
(1.71%)
332.94 USD
Z
ZBH
-0.280
(-0.25%)
111.100 USD
News

Title: ResMed

Sector: Healthcare
Industry: Medical Instruments & Supplies
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.